COVID-19 GUIDELINES have been published by the Australian and New Zealand Intensive Care Society (ANZICS). These are written from the intensive care perspective and may be of assistance in the development of local management strategies.
INTERIM CLINICAL GUIDANCE has been developed by a Task Force in Belgium and was published on March 16th.
The European Society of Intensive Care Medicine (ESICM) has recently shared some experience and guidance from colleagues in Northern Italy. ESICM also hosted a series of webinars:
February 26th with First hand experience of the situation in China;
March 9th about Managing critically ill patients with the virus;
March 16th on National Co-ordination and Experience in Italy.
The Sociedad Portuguesa de Cuidados Intensivos (SPCI) has published recommendations in the Portuguese language.
The AMA COVID-19 Resource Centre provides evidence-based perspectives on how physicians can prepare themselves and their practices for a potential pandemic scenario.
The World Health Organisation website has resources you can access.
The Centers for Diseases Control and Prevention provides updated information as it becomes available.WFICC intends to keep fully up-to-date as the COVID-19 issue develops and will communicate with our society members in the global intensive and critical care community.
The American College of Physicians (ACP) has developed a free to access online learning activity with a clinical overview and patient care guidance.
2019 Novel Coronavirus (2019-nCOV)
Professional colleagues will be aware of reports concerning the outbreak of 2019 novel coronavirus (2019-nCov), which has infected at least 300 people in China. Cases have also been identified on others countries including South Korea, Japan and the USA.
The WFICC is monitoring reports from the Centres for Disease Control and Prevention (CDC) and the World Health Organization. The CDC has issued interim guidance for healthcare professionals that includes criteria to guide evaluations of patients under investigation for the 2019-nCov, as well as infection prevention and control recommendations.
Below is an overview of the evaluation criteria:
- Fever AND symptoms of lower respiratory illness (e.g., cough, shortness of breath)–and in the last 14 days before symptom onset, History of travel from Wuhan City, China Close contact with a person who is under investigation for 2019-nCoV while that person was ill.
- Fever OR symptoms of lower respiratory illness (e.g., cough, shortness of breath) –and in the last 14 days before symptom onset, Close contact with an ill laboratory-confirmed 2019-nCoV patient WFICC intends to keep fully up-to-date as this issue develops and will communicate with our society members in the global intensive and critical care community.
Thank you for remaining diligent and safe as we remain dedicated to our mission of promoting the highest standards of intensive and critical care for all humankind, without discrimination.